GrahamB wrote:
Stetsen wrote: Just woke up from a crazy dream about Fsd becoming a very high demand company and the stock prices was over 1,000.00 per share. Then I saw this!
https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-patients-news-alert-30sec/
Good to hear you are back and well Niet
You must have been sad to wake up from your dream and see the price was down 95% from where it was when you were buying and promoting others buy.
1000.00 adjusted for the 201-1 split is still lower that what you were predicting about a year ago.
That was a dream as well.
Unfortunately the other dream about the baby being born in April, being the worlds biggest cannabis producer and growing cannabis in spiral fashion to the ceiling of the coburg building that was worth 400 million, retail shops, Are now a dream as well.
All the highly touted partnerships worth incalculable amounts-a dream
(Although we are still waiting to hear if they can grown cannabis from algae- keep dreaming-in my view)
Will FSD use micro PEA to treat the cytokines storm?
In short I predict this is also highly unlikely and a dream.
Why-it is a relatively weak, but safe , nutraceutical
As I noted before....There are many many candidates being studied, but one of the most interesting involves the JAK kinase inhibitors.
These molecules, like Baricitinib may not only able to block the penetration of the coronavirus through the ACE2 receptor, but also can shut down the powerful immune response which may be partly responsible for the fatal ARDS.(check out the AI initiative that found this-very cool)
There is a huge amount of research here, and very very exciting, and promising
Where does this leave FSD and the rebranded but well known nutraceutical?
Once again, in my view, more hype than beef, and too little too late.
Essentially, the time that it’s going to take them to get up and running, with the declining cases, and the heavy competition, in my view, is ill timed, and thin on promise.
On the one hand, I think it’s great that they decided to help out in this public healthbattle. Alternatively, with their limited and dwindling resources, this is an ill timed, and very risky initiative.
If they are not successful, and remember 95% of clinical trials are not, then where do they go? If they are to go onto a second clinical trial program as they were going to with osteoarthritis or neurological conditions, where will they get the cash? Time will have passed.
Sorry guys, but I am a realist, an evidence-based investor, and I love biotech...
Not to throw water on the fire, but I think that this article from Dr Rs hometown and a quoted analyst in the article said it best:
“Investors may be overvaluing FSD’s tidbit of news.
Getting approval to submit an application does not mean the application has been approved by the FDA, said Dan Hoffman, a consultant to the pharmaceutical industry.
“The FDA is going to want to see any number of things before that happens,” Hoffman said. “Everything from HIPAA [patient privacy] protections to what contractors and testing sites they’re going to use.... “If they’re just getting ready to request authorization for starting clinical trials, [FSD Pharma is] going to be well behind any number of companies with compounds to control cytokine storms," Hoffman said. “You’ve got to wonder if there is going to be much global demand for anything to do with coronavirus by the time they’re ready.”
https://www.inquirer.com/business/drugs/cannabis-related-drug-fsd-fda-covid-19-immune-system-20200603.html
While dreams can be a pleasant diversion-I find solace in reality, facts, and the knowledge that my money is working for me, and not in a promoters pocket.